240 related articles for article (PubMed ID: 18155170)
1. Src family kinases and the MEK/ERK pathway in the regulation of myeloid differentiation and myeloid leukemogenesis.
Johnson DE
Adv Enzyme Regul; 2008; 48():98-112. PubMed ID: 18155170
[No Abstract] [Full Text] [Related]
2. BAALC potentiates oncogenic ERK pathway through interactions with MEKK1 and KLF4.
Morita K; Masamoto Y; Kataoka K; Koya J; Kagoya Y; Yashiroda H; Sato T; Murata S; Kurokawa M
Leukemia; 2015 Nov; 29(11):2248-56. PubMed ID: 26050649
[TBL] [Abstract][Full Text] [Related]
3. Cytokine-induced myeloid differentiation is dependent on activation of the MEK/ERK pathway.
Miranda MB; Xu H; Torchia JA; Johnson DE
Leuk Res; 2005 Nov; 29(11):1293-306. PubMed ID: 16164983
[TBL] [Abstract][Full Text] [Related]
4. MEK-ERK signaling plays diverse roles in the regulation of facial chondrogenesis.
Bobick BE; Kulyk WM
Exp Cell Res; 2006 Apr; 312(7):1079-92. PubMed ID: 16457813
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori CagA induces ornithine decarboxylase upregulation via Src/MEK/ERK/c-Myc pathway: implication for progression of gastric diseases.
Xu X; Liu Z; Fang M; Yu H; Liang X; Li X; Liu X; Chen C; Jia J
Exp Biol Med (Maywood); 2012 Apr; 237(4):435-41. PubMed ID: 22442341
[TBL] [Abstract][Full Text] [Related]
6. Src-family kinases play an essential role in differentiation signaling downstream of macrophage colony-stimulating factor receptors mediating persistent phosphorylation of phospholipase C-gamma2 and MAP kinases ERK1 and ERK2.
Bourgin-Hierle C; Gobert-Gosse S; Thérier J; Grasset MF; Mouchiroud G
Leukemia; 2008 Jan; 22(1):161-9. PubMed ID: 17972959
[TBL] [Abstract][Full Text] [Related]
7. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.
Roberts PJ; Der CJ
Oncogene; 2007 May; 26(22):3291-310. PubMed ID: 17496923
[TBL] [Abstract][Full Text] [Related]
8. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
9. Targeting Raf/MEK/ERK pathway in pituitary adenomas.
Suojun Z; Feng W; Dongsheng G; Ting L
Eur J Cancer; 2012 Feb; 48(3):389-95. PubMed ID: 22119203
[TBL] [Abstract][Full Text] [Related]
10. Intestinal epithelial cancer cell anoikis resistance: EGFR-mediated sustained activation of Src overrides Fak-dependent signaling to MEK/Erk and/or PI3-K/Akt-1.
Demers MJ; Thibodeau S; Noël D; Fujita N; Tsuruo T; Gauthier R; Arguin M; Vachon PH
J Cell Biochem; 2009 Jul; 107(4):639-54. PubMed ID: 19479902
[TBL] [Abstract][Full Text] [Related]
11. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE
Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544
[TBL] [Abstract][Full Text] [Related]
12. The protein kinase C agonist prostratin induces differentiation of human myeloid leukemia cells and enhances cellular differentiation by chemotherapeutic agents.
Shen X; Xiong GL; Jing Y; Xiao H; Cui Y; Zhang YF; Shan YJ; Xing S; Yang M; Liu XL; Dong B; Wang LS; Luo QL; Yu ZY; Cong YW
Cancer Lett; 2015 Jan; 356(2 Pt B):686-96. PubMed ID: 25449427
[TBL] [Abstract][Full Text] [Related]
13. Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways.
Bouchard V; Demers MJ; Thibodeau S; Laquerre V; Fujita N; Tsuruo T; Beaulieu JF; Gauthier R; Vézina A; Villeneuve L; Vachon PH
J Cell Physiol; 2007 Sep; 212(3):717-28. PubMed ID: 17443665
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase, p38 mitogen-activated protein kinase (MAPK), extracellular signal-regulated kinase MAPK, Rho kinase, and Src mediate hydrogen peroxide-induced contraction of rat thoracic aorta and vena cava.
Thakali K; Davenport L; Fink GD; Watts SW
J Pharmacol Exp Ther; 2007 Jan; 320(1):236-43. PubMed ID: 17003231
[TBL] [Abstract][Full Text] [Related]
15. 1Alpha,25-dihydroxyvitamin D3-mediated stimulation of steroid sulphatase activity in myeloid leukaemic cell lines requires VDRnuc-mediated activation of the RAS/RAF/ERK-MAP kinase signalling pathway.
Hughes PJ; Brown G
J Cell Biochem; 2006 Jun; 98(3):590-617. PubMed ID: 16440327
[TBL] [Abstract][Full Text] [Related]
16. Modulation of Raf/MEK/ERK kinase activity does not affect the chemoresistance profile of advanced prostate cancer cells.
Lee JT; Steelman LS; McCubrey JA
Int J Oncol; 2005 Jun; 26(6):1637-44. PubMed ID: 15870880
[TBL] [Abstract][Full Text] [Related]
17. Hijacking the ERK signaling pathway: Mycobacterium leprae shuns MEK to drive the proliferation of infected Schwann cells.
Noon LA; Lloyd AC
Sci STKE; 2005 Nov; 2005(309):pe52. PubMed ID: 16278488
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid receptor 1 induces a biphasic ERK activation via multiprotein signaling complex formation of proximal kinases PKCε, Src, and Fyn in primary neurons.
Asimaki O; Mangoura D
Neurochem Int; 2011 Feb; 58(2):135-44. PubMed ID: 21074588
[TBL] [Abstract][Full Text] [Related]
19. [Spatio-temporal regulation of ERK1/2 MAP kinase].
Yamamoto T; Nishida E
Tanpakushitsu Kakusan Koso; 2007 Jun; 52(7):747-52. PubMed ID: 17552279
[No Abstract] [Full Text] [Related]
20. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity.
Lue H; Kapurniotu A; Fingerle-Rowson G; Roger T; Leng L; Thiele M; Calandra T; Bucala R; Bernhagen J
Cell Signal; 2006 May; 18(5):688-703. PubMed ID: 16122907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
